Rigg Khary K, Weiner Michael A, Kusiak Ethan S
Department of Mental Health Law & Policy, University of South Florida, 13301 Bruce B. Downs Blvd, Tampa, FL, 33612, USA.
J Behav Health Serv Res. 2025 Apr;52(2):200-212. doi: 10.1007/s11414-024-09878-3. Epub 2024 Mar 11.
In the United States, opioid-related deaths involving polydrug use are now more prevalent than those involving only opioids. What often goes unnoticed is that deaths involving more than one substance are increasing more rapidly among Black Americans than Whites. Unfortunately, little research attention is paid to understanding opioid-related polydrug use patterns among Black Americans. As a result, less is known regarding which drug combinations are most common among this population and their reasons for co-using certain drugs. Therefore, the objective of this mixed methods study was to identify which substances were most commonly co-used with opioids among Black Americans, while also capturing their motives for combining opioids with other drugs. This study used data from the Florida Minority Health Study, a mixed-methods project that included online surveys (n = 303) and qualitative in-depth interviews (n = 30) of Black Americans who misuse opioids. Data collection was conducted from August 2021 to February 2022 throughout Southwest Florida. Analyses revealed that opioids were most commonly combined with alcohol, cocaine, and methamphetamine, respectively. Opioids were co-used with alcohol in an attempt to enhance the desired effect (i.e., intoxication), while stimulants and opioids were combined to counteract the undesirable side effects of the other. This study begins to answer the question of which/why substances are combined with opioids among Black Americans and should inform behavioral health interventions targeted at this population. Data on this topic are especially timely as the United States goes through the current fourth wave of the opioid crisis that is characterized by deaths due to polydrug use. These findings invite further study using nationally representative data to determine the extent to which polydrug using patterns differ across racial/ethnic groups.
在美国,涉及多药合用的阿片类药物相关死亡现在比仅涉及阿片类药物的死亡更为普遍。常常被忽视的是,涉及多种物质的死亡在美国黑人中比白人增加得更快。不幸的是,很少有研究关注美国黑人中与阿片类药物相关的多药合用模式。因此,对于该人群中哪些药物组合最常见以及他们同时使用某些药物的原因,人们了解得更少。因此,这项混合方法研究的目的是确定在美国黑人中哪些物质最常与阿片类药物同时使用,同时了解他们将阿片类药物与其他药物合用的动机。本研究使用了佛罗里达少数族裔健康研究的数据,这是一个混合方法项目,包括对滥用阿片类药物的美国黑人进行的在线调查(n = 303)和定性深入访谈(n = 30)。数据收集于2021年8月至2022年2月在佛罗里达州西南部进行。分析显示,阿片类药物最常分别与酒精、可卡因和甲基苯丙胺合用。阿片类药物与酒精合用是为了增强预期效果(即醉酒),而兴奋剂和阿片类药物合用是为了抵消对方的不良副作用。这项研究开始回答在美国黑人中哪些/为什么物质与阿片类药物合用的问题,并应为针对该人群的行为健康干预提供信息。由于美国正在经历当前以多药合用导致死亡为特征的第四波阿片类药物危机,关于这一主题的数据尤为及时。这些发现促使人们使用具有全国代表性的数据进行进一步研究,以确定多药合用模式在不同种族/族裔群体中的差异程度。